Berberine reverses epithelial-to-Mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human ervical cancer cells

Molecular Pharmacology

Volumn 86, Issue 6, 2014, Pages 609-623

  Chu, Shu Chen ^a   Yu, Cheng Chia ^b,e   Hsu, Li Sung ^c   Chen, Kuo Shuen ^d,e   Su, Mei Yu ^c,e   Chen, Pei Ni ^c,e  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b School of Dentistry   (Taiwan)

^c Institute of Biochemistry and Biotechnology   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CLAUDIN 1; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE; UVOMORULIN; BETA CATENIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL ADHESION; CELL INVASION; CELL VIABILITY; CERVICAL CANCER CELL LINE; CHICKEN; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FOCAL ADHESION; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC ZEBRAFISH; TRANSIENT TRANSFECTION; TUMOR XENOGRAFT; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING; ZEBRA FISH; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; CHORIOALLANTOIS; DRUG EFFECTS; METABOLISM; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVICAL NEOPLASMS;

ANIMALS; BERBERINE; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CHICKENS; CHORIOALLANTOIC MEMBRANE; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MICE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; UTERINE CERVICAL NEOPLASMS; ZEBRAFISH;

EID: 84912028486     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.094037     Document Type: Article

References (41)

1. Chen PN, Chu SC, Chiou HL, Chiang CL, Yang SF, and Hsieh YS (2005) Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr Cancer 53:232-243.
2. Chen PN, Chu SC, Kuo WH, Chou MY, Lin JK, and Hsieh YS (2011) Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells. J Agric Food Chem 59:3836-3844.
3. Chen JS, Huang XH, Wang Q, Chen XL, Fu XH, Tan HX, Zhang LJ, Li W, and Bi J (2010) FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin Exp Metastasis 27:71-82.
4. Chiu HY, Sun KH, Chen SY, Wang HH, Lee MY, Tsou YC, Jwo SC, Sun GH, and Tang SJ (2012) Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells. Cytokine 59:423-432.
5. de Herreros AG, Peiró S, Nassour M, and Savagner P (2010) Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia 15:135-147.
6. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, and Lu Z (2007) Phosphorylation of beta-catenin by AKT promotes betacatenin transcriptional activity. J Biol Chem 282:11221-11229.
7. Garouniatis A, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, and Papavassiliou AG (2013) FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk. Int J Colorectal Dis 28:9-18.
8. Hanahan D and Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70.
9. Ho ML, Chen PN, Chu SC, Kuo DY, Kuo WH, Chen JY, and Hsieh YS (2010) Peonidin 3-glucoside inhibits lung cancer metastasis by downregulation of proteinases activities and MAPK pathway. Nutr Cancer 62:505-516.
10. Ho ML, Hsieh YS, Chen JY, Chen KS, Chen JJ, Kuo WH, Lin SJ, and Chen PN (2011) Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo. Evid Based Complement Alternat Med 2011:507920.
11. Hsieh YS, Chu SC, Hsu LS, Chen KS, Lai MT, Yeh CH, and Chen PN (2013) Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells. Food Chem Toxicol 62:908-918.
12. Hu FW, Tsai LL, Yu CH, Chen PN, Chou MY, and Yu CC (2012) Impairment of tumorinitiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. Mol Nutr Food Res 56: 1247-1258.
13. Inge LJ, Rajasekaran SA, Wolle D, Barwe SP, Ryazantsev S, Ewing CM, Isaacs WB, and Rajasekaran AK (2008) alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling. Mol Cancer Ther 7:1386-1397.
14. Javelaud D, Poupon MF, Wietzerbin J, and Besançon F (2002) Inhibition of constitutive NF-kappa B activity suppresses tumorigenicity of Ewing sarcoma EW7 cells. Int J Cancer 98:193-198.
15. Jie S, Li H, Tian Y, Guo D, Zhu J, Gao S, and Jiang L (2011) Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro. J Gastroenterol Hepatol 26:179-185.
16. Kim HJ, Kim YM, Lim S, Nam YK, Jeong J, Kim HJ, and Lee KJ (2009) Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene 28:117-127.
17. Lan YQ, Zhang C, Xiao JH, Zhuo YH, Guo H, Peng W, and Ge J (2009) Suppression of IkappaBalpha increases the expression of matrix metalloproteinase-2 in human ciliary muscle cells. Mol Vis 15:1977-1987.
18. Lawson ND and Weinstein BM (2002) In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248:307-318.
19. Lin CH, Hsiao YM, Ou CC, Lin YW, Chiu YL, Lue KH, Chang JG, and Ko JL (2010) GMI, a Ganoderma immunomodulatory protein, down-regulates tumor necrosis factor a-induced expression of matrix metalloproteinase 9 via NF-kB pathway in human alveolar epithelial A549 cells. J Agric Food Chem 58:12014-12021.
20. Lin S, Tsai SC, Lee CC, Wang BW, Liou JY, and Shyu KG (2004) Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol Pharmacol 66:612-619.
21. Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, and Das BC (2011) Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer 10:39.
22. Mantena SK, Sharma SD, and Katiyar SK (2006a) Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 27:2018-2027.
23. Mantena SK, Sharma SD, and Katiyar SK (2006b) Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 5:296-308.
24. Orsulic S, Huber O, Aberle H, Arnold S, and Kemler R (1999) E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 112:1237-1245.
25. Park JM, Kim A, Oh JH, and Chung AS (2007) Methylseleninic acid inhibits PMAstimulated pro-MMP-2 activationmediated byMT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation. Carcinogenesis 28:837-847.
26. Pulyaeva H, Bueno J, Polette M, Birembaut P, Sato H, Seiki M, and Thompson EW(1997) MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 15:111-120.
27. Rabbani GH, Butler T, Knight J, Sanyal SC, and Alam K (1987) Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis 155:979-984.
28. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489-501.
29. Roberts AB and Wakefield LM (2003) The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA 100:8621-8623.
30. Roomi MW, Kalinovsky T, Rath M, and Niedzwiecki A (2012) Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines. Oncol Rep 28:768-776.
31. Shah PP, Fong MY, and Kakar SS (2012) PTTG induces EMT through integrin αVβ3- focal adhesion kinase signaling in lung cancer cells. Oncogene 31:3124-3135.
32. Sliva D (2004) Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr Cancer Drug Targets 4:327-336.
33. Sliva D, English D, Lyons D, and Lloyd FP, Jr (2002) Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB. Biochem Biophys Res Commun 290:552-557.
34. Smith RA, Brooks D, Cokkinides V, Saslow D, and Brawley OW (2013) Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin 63:88-105.
35. Tee YT, Wang PH, Tsai HT, Lin LY, Lin HT, Yang SF, Hsieh YH, and Ying TH (2012) Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia. J Surg Oncol 106:204-208.
36. Tian X, Song Y, Dong H, and Ye B (2008) Interaction of anticancer herbal drug berberine with DNA immobilized on the glassy carbon electrode. Bioelectrochemistry 73:18-22.
37. Tseng RC, Lee SH, Hsu HS, Chen BH, Tsai WC, Tzao C, and Wang YC (2010) SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis. Cancer Res 70:543-551.
38. Vaupel P (2004) Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14:198-206.
39. Xie F, Meng YH, Liu LB, Chang KK, Li H, Li MQ, and Li DJ (2013) Cervical carcinoma cells stimulate the angiogenesis through TSLP promoting growth and activation of vascular endothelial cells. Am J Reprod Immunol 70:69-79.
40. Yu HH, Kim KJ, Cha JD, Kim HK, Lee YE, Choi NY, and You YO (2005) Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J Med Food 8:454-461.
41. Zhao M, Gao Y, Wang L, Liu S, Han B, Ma L, Ling Y, Mao S, and Wang X (2013) Overexpression of integrin-linked kinase promotes lung cancer cell migration and invasion via NF-kB-mediated upregulation of matrix metalloproteinase-9. Int J Med Sci 10:995-1002.